RING CHRISTINE (General Counsel) sold 23.5% of their position (8.15K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $124.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/2/2026ACC: 0001817199-26-000012
Officer· General Counsel
Since Jul 2020
-8.15K
Net shares
Net seller
$124.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.15K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.15K
Price / share
$15.24
Trade value
$124.15K
% of position
23.5%
4/2/2026
34.60K→26.45K
Total
Net shares
−8.15K
Net value
-$124.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/2/2026 | S · Sale | −8.15K | $15.24 | $124.15K | 23.5% | 34.60K | 26.45K |
| Total | −8.15K | -$124.15K | ||||||
Derivative Transactions0
No derivative transactions reported